HOME > MARKETS > COMPANY NEWS
  COMPANY NEWS
COMPANY
Fabtech Technologies secures contract worth Rs 31.23 crore
Jun-15-2026

Fabtech Technologies has secured a contract worth Rs 31.23 crore for the critical internal infrastructure scope of a new Veterinary Vaccine Manufacturing Facility in Botswana. The project further strengthens the company’s growing presence across Africa’s healthcare, biotechnology, and vaccine manufacturing sectors. Under the project scope, the company will deliver advanced GMP-compliant internal infrastructure, precision HVAC systems, clean utilities, and critical MEP services engineered to international manufacturing standards. Fabtech will provide an integrated infrastructure platform designed for safe, efficient, and scalable vaccine production. 

Beyond veterinary healthcare, the project strengthens the company’s position within Africa’s emerging vaccine and biologics manufacturing ecosystem. The infrastructure being deployed today lays the foundation for broader capabilities in critical vaccines, biological products, and sterile injectable manufacturing across the continent, supporting Africa’s long-term ambition of healthcare and vaccine self-sufficiency.

Fabtech Technologies is a key turnkey engineering solution provider in pharmaceuticals capex space, offering comprehensive start to finish solutions encompassing designing, engineering, procurement, installation and testing of pharmaceutical equipment for a wide range of customers.

  RELATED NEWS >>